Securities Code: 301367
Securities Abbreviation: Remeet
Announcement Number: 2026-048
Beijing Remeet Medical Technology Co., Ltd.
Announcement on the Completion of Board of Directors Reshuffle and Election of Chairman, Members of Special Committees, Senior Management, Securities Affairs Representative, and Internal Audit Head
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed herein, and are free from any false representations, misleading statements, or material omissions.
Beijing Remeet Medical Technology Co., Ltd. (hereinafter referred to as the "Company") held its first Employee Representative Meeting in 2026 on June 11, 2026, and elected employee directors for the fourth Board of Directors. On the same day, the Company held the first meeting of the fourth Board of Directors, which considered and approved the Proposal on the Election of the Chairman of the Fourth Board of Directors, the Proposal on the Election of Members of the Special Committees of the Fourth Board of Directors, the Proposal on the Appointment of the General Manager, the Proposal on the Appointment of the Deputy General Managers, the Proposal on the Appointment of the Board Secretary, the Proposal on the Appointment of the Chief Financial Officer, the Proposal on the Appointment of the Securities Affairs Representative, and the Proposal on the Appointment of the Internal Audit Head. The relevant matters are hereby announced as follows:
I. Composition of the Fourth Board of Directors
Non-independent Directors: Mr. Zhuang Zhi, Ms. Chen Bei, Mr. Zhou Mingzhao, Mr. Cui Wenli, Mr. TAN CHING (Tan Qing)
Directors elected by employees: Mr. Gao Chengwei
Independent Directors: Mr. Shen Jiayun, Mr. Wang Guangzhi, Mr. Wang Lihua
The term of the fourth Board of Directors is three years, commencing from the date of approval by the first extraordinary general meeting of shareholders in 2026/the first employee representative meeting in 2026 until the expiration of the term of the fourth Board of Directors.
The above personnel meet the qualifications for directors of listed companies as stipulated by relevant laws, regulations, and normative documents. They are not subject to any circumstances that would disqualify them from serving as directors under the "Company Law of the People's Republic of China" (hereinafter referred to as the "Company Law") or the "Self-Regulatory Guidelines for the Listing of Companies on the ChiNext Market of the Shenzhen Stock Exchange No. 2 - Standardized Operation of Listed Companies on the ChiNext Market" (hereinafter referred to as the "Standardized Operation Guidelines") and its amendments, nor are they persons prohibited from market entry by the China Securities Regulatory Commission (CSRC) who have not yet had the prohibition lifted. They have not been penalized or sanctioned by the CSRC or other relevant authorities or stock exchanges, nor are they listed as dishonest judgment debtors. The qualifications and independence of the independent directors were reviewed and approved by the Shenzhen Stock Exchange prior to the first extraordinary general meeting of shareholders in 2026. The number of directors who are also senior management personnel or employee representatives shall not exceed one-half of the total number of directors of the fourth Board of Directors. The proportion of independent directors meets the requirements of relevant regulations and the Articles of Association.
II. Chairman of the Board
Mr. Zhuang Zhi serves as the Chairman of the Board. His term of office begins from the date of approval of the first meeting of the fourth Board of Directors and ends upon the expiration of the term of the fourth Board of Directors.
III. Composition of the Special Committees of the Fourth Board of Directors
The Board of Directors has established four special committees: the Audit Committee, the Nomination Committee, the Compensation and Remuneration Committee, and the Strategy Committee. The Board of Directors has elected the following members to serve on the special committees of the fourth Board of Directors. The composition of each special committee is as follows: